April 5, 2024
Input needed: FDA’s demonstrably difficult rule
Before APC determines its position and prepares comments to FDA on the proposed rule, we want to hear from you.
April 5, 2024
A cardiologist tells the truth
If you haven’t read it yet, an excellent commentary was published in Medscape this week by a cardiologist and obesity specialist. He pushes back against rampant misinformation around compounded GLP-1s.
March 28, 2024
Yes, we’re reviewing that ‘demonstrably difficult’ proposed rule
It’s been breathlessly anticipated for months, and this week it finally published: an FDA proposed rule regarding the Demonstrably Difficult to Compound list.
March 28, 2024
10 days left to apply for APC Fellowship
Since the program’s inception in 1997, 162 professionals have been honored as APC Fellows.
March 28, 2024
Wedgewood is APC’s newest Silver-level supporter
Long-time APC supporter Wedgewood Pharmacy, a compounder focused exclusively on animal health, is our newest 2024 Silver-level Corporate Patron.
March 28, 2024
FDA wants to issue guidance docs without public comment
In a draft report and plan for guidance documents released by FDA earlier this year, the agency indicated that it intends to issue guidance documents without a public notice and comment period.
March 28, 2024
Damned if we do, damned if we don’t
Let’s say you’re APC. You get a call from a producer at a major news network saying that their celebrity medical doctor is doing a story on GLP-1 drugs and wants to include compounded GLP-1s in the piece.
March 18, 2024
CC: March 15, 2024
From APC: Tutoring a federal appeals court and other big news | 15 March 2024
